Literature DB >> 16275883

Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.

Elina Minami1, Michael A Laflamme, Jeffrey E Saffitz, Charles E Murry.   

Abstract

BACKGROUND: Extracardiac progenitor cells are capable of repopulating cardiomyocytes at very low levels in the human heart after injury. Here, we explored the extent of endothelial, smooth muscle, and Schwann cell chimerism in patients with sex-mismatched (female-to-male) heart transplants. METHODS AND
RESULTS: Autopsy specimens from 5 patients and endomyocardial biopsies from 7 patients were used for this study. Endothelial, vascular smooth muscle, and Schwann cells were stained with antibodies against CD31 or Ulex europaeus lectin, smooth muscle alpha-actin, and S-100, respectively, and the Y chromosome was identified with in situ hybridization. Biopsy specimens from 1, 4, 6, and 12 months and 5 and 10 years after heart transplantation were evaluated. Y-positive cells were counted by conventional bright-field microscopy and confirmed by confocal microscopy. Endothelial cells showed the highest degree of chimerism, averaging 24.3+/-8.2% from extracardiac sources. Schwann cells showed the next highest chimerism, averaging 11.2+/-2.1%; vascular smooth muscle cells averaged 3.4+/-1.8%. All 3 cell types showed substantially higher chimerism than we previously observed for cardiomyocytes (0.04+/-0.05%). Endothelial chimerism was much higher in the microcirculation than in larger vessels. Analysis of serial endomyocardial biopsies revealed that high levels of endothelial chimerism occurred as early as 1 month after transplantation (22+/-6.6%) with no significant increases even up to 10 years after cardiac transplantation.
CONCLUSIONS: Extracardiac progenitor cells are capable of repopulating most major cell types in the heart, but they do so with varying frequency. The signals for endothelial progenitor recruitment occur early and could relate to injury during allograft harvest or transplantation. The high degree of endothelial chimerism may have immune implications such as for myocardial rejection or graft vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275883     DOI: 10.1161/CIRCULATIONAHA.105.576017

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

1.  The human heart: a self-renewing organ.

Authors:  Jan Kajstura; Toru Hosoda; Claudia Bearzi; Marcello Rota; Silvia Maestroni; Konrad Urbanek; Annarosa Leri; Piero Anversa
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

Review 2.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies.

Authors:  Rachel Ruckdeschel Smith; Lucio Barile; Elisa Messina; Eduardo Marbán
Journal:  Heart Rhythm       Date:  2008-02-15       Impact factor: 6.343

3.  Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.

Authors:  Robert S Kerbel; Robert Benezra; David C Lyden; Koichi Hattori; Beate Heissig; Daniel J Nolan; Vivek Mittal; Yuval Shaked; Sergio Dias; Francesco Bertolini; Shahin Rafii
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-20       Impact factor: 11.205

4.  In situ genetic analysis of cellular chimerism.

Authors:  David Wu; Quynh Vu; Anhthu Nguyen; James R Stone; Hannah Stubbs; Georgiana Kuhlmann; Lynette M Sholl; A John Iafrate
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

Review 5.  Lessons and limits of mouse models.

Authors:  Anita S Chong; Maria-Luisa Alegre; Michelle L Miller; Robert L Fairchild
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

Review 6.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

7.  VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.

Authors:  Marilyn B Nourse; Daniel E Halpin; Marta Scatena; Derek J Mortisen; Nathaniel L Tulloch; Kip D Hauch; Beverly Torok-Storb; Buddy D Ratner; Lil Pabon; Charles E Murry
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-29       Impact factor: 8.311

8.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.

Authors:  Daniel J Nolan; Alessia Ciarrocchi; Albert S Mellick; Jaspreet S Jaggi; Kathryn Bambino; Sunita Gupta; Emily Heikamp; Michael R McDevitt; David A Scheinberg; Robert Benezra; Vivek Mittal
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

Review 9.  AIP1 in graft arteriosclerosis.

Authors:  Wang Min; Jordan S Pober
Journal:  Trends Cardiovasc Med       Date:  2011-11       Impact factor: 6.677

Review 10.  Cardiogenic differentiation and transdifferentiation of progenitor cells.

Authors:  Hans Reinecke; Elina Minami; Wei-Zhong Zhu; Michael A Laflamme
Journal:  Circ Res       Date:  2008-11-07       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.